05/15/2024 6:13 AM | Acurx Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 3:05 PM | Acurx Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/03/2024 8:55 PM | Acurx Pharmaceuticals (Issuer) DELUCCIA ROBERT J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 8:56 PM | Acurx Pharmaceuticals (Issuer) Shawah Robert G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 8:56 PM | Acurx Pharmaceuticals (Issuer) LUCI DAVID P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 6:31 AM | Acurx Pharmaceuticals (Subject)
| Form FWP | |
03/29/2024 3:58 PM | Acurx Pharmaceuticals (Filer)
| Form S-1/A | |
03/15/2024 3:33 PM | Acurx Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024 1:39 PM | Acurx Pharmaceuticals (Subject) ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
01/22/2024 5:15 AM | Acurx Pharmaceuticals (Issuer) Sailer Carl (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:24 PM | Acurx Pharmaceuticals (Issuer) LUCI DAVID P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:49 PM | Acurx Pharmaceuticals (Filer)
| Form 424B5 | |
11/14/2023 3:05 PM | Acurx Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2023 3:41 PM | Acurx Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 6:10 AM | Acurx Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 3:05 PM | Acurx Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/13/2023 3:32 PM | Acurx Pharmaceuticals (Filer)
| Form 424B3 | |
07/10/2023 11:15 PM | Acurx Pharmaceuticals (Filer)
| Form EFFECT | |
06/20/2023 3:44 PM | Acurx Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2023 4:45 PM | Acurx Pharmaceuticals (Issuer) Scodari Joseph C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 4:45 PM | Acurx Pharmaceuticals (Issuer) Sailer Carl (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 4:45 PM | Acurx Pharmaceuticals (Issuer) DEAN JACK H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 4:46 PM | Acurx Pharmaceuticals (Issuer) HARRISON THOMAS L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 4:46 PM | Acurx Pharmaceuticals (Issuer) Donohue James J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |